BNIP3 and chronic kidney disease: (2023) reported that COPT could reduce the expression of mtROS and fibrosis markers, reduced the occurrence of apoptosis, significantly improved AKI, and reduced kidney fibrosis in mice with CKD by inducing BNIP3 mediated mitophagy, while having good biocompatibility.